Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulocyte transfusion.

Ehab Atallah1, Charles A Schiffer

  • 1Divison of Hematology/Oncology, Karmanos Cancer Institute, Detroit, Michigan 48201, USA.

Current Opinion in Hematology
|December 2, 2005
PubMed
Summary

Granulocyte transfusions can help control severe infections in neutropenic patients, especially when combined with granulocyte colony-stimulating factor. However, timely availability and donor compatibility remain challenges for this therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy.

Leukemia & lymphoma·2026
Same author

Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Leukemia & lymphoma·2026
Same author

Randomized trial of thulium laser-assisted tumor bed coagulation versus conventional suture renorrhaphy in laparoscopic partial nephrectomy: impact on perioperative outcomes and fibrosis biomarker response.

World journal of urology·2025
Same author

Improving quality of life for patients with chronic myeloid leukemia through supportive care, low-dose therapy, switching, and treatment-free remission.

Haematologica·2025
Same author

Expert consensus definition of treatment intolerance in chronic myeloid leukemia in chronic phase.

Hematology (Amsterdam, Netherlands)·2025
Same author

Outcomes of older patients with TP53-mutated myeloid neoplasms.

Blood cancer journal·2025

Area of Science:

  • Hematology
  • Transfusion Medicine
  • Infectious Diseases

Background:

  • Granulocyte transfusions have a long history but faced challenges in efficacy analysis due to evolving treatments and patient factors.
  • The advent of granulocyte colony-stimulating factor has renewed interest and improved yields for granulocyte transfusion therapy.

Purpose of the Study:

  • To review recent studies on granulocyte transfusion therapy.
  • To assess the clinical applicability and effectiveness of current granulocyte transfusion protocols.

Main Methods:

  • Review of recent clinical studies and literature on granulocyte transfusion.
  • Analysis of data regarding granulocyte yield, patient response rates, and side effects.
  • Evaluation of donor selection and compatibility methods.

Main Results:

  • Granulocyte colony-stimulating factor increased granulocyte yield significantly (approx. fourfold).
  • Granulocyte transfusions demonstrated response rates of 40-80% in controlling severe infections unresponsive to antibiotics.
  • Severe side effects were rare, but benefits are limited to a specific patient subset.

Conclusions:

  • Granulocyte transfusions are effective for neutropenic patients with severe, uncontrolled infections.
  • Patient outcomes are primarily determined by the underlying disease.
  • Challenges include timely transfusion availability and optimizing donor-recipient compatibility, especially for alloimmunized patients.

Related Experiment Videos